AU3760595A - Methods for regulation of insulin-like growth factor i receptor - Google Patents

Methods for regulation of insulin-like growth factor i receptor

Info

Publication number
AU3760595A
AU3760595A AU37605/95A AU3760595A AU3760595A AU 3760595 A AU3760595 A AU 3760595A AU 37605/95 A AU37605/95 A AU 37605/95A AU 3760595 A AU3760595 A AU 3760595A AU 3760595 A AU3760595 A AU 3760595A
Authority
AU
Australia
Prior art keywords
insulin
receptor
regulation
methods
growth factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37605/95A
Inventor
Patrick Delafontaine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emory University
Original Assignee
Emory University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emory University filed Critical Emory University
Publication of AU3760595A publication Critical patent/AU3760595A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/13—Decoys
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU37605/95A 1994-10-04 1995-09-27 Methods for regulation of insulin-like growth factor i receptor Abandoned AU3760595A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31789894A 1994-10-04 1994-10-04
US317898 1994-10-04
PCT/US1995/012563 WO1996010401A1 (en) 1994-10-04 1995-09-27 Methods for regulation of insulin-like growth factor i receptor

Publications (1)

Publication Number Publication Date
AU3760595A true AU3760595A (en) 1996-04-26

Family

ID=23235734

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37605/95A Abandoned AU3760595A (en) 1994-10-04 1995-09-27 Methods for regulation of insulin-like growth factor i receptor

Country Status (2)

Country Link
AU (1) AU3760595A (en)
WO (1) WO1996010401A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM672594A0 (en) 1994-07-08 1994-08-04 Royal Children's Hospital Research Foundation A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders
JP2002501482A (en) * 1997-01-16 2002-01-15 ユニバーシティ・オブ・フロリダ・リサーチ・ファンデーション・インコーポレーテッド Compositions for enhancing the cytoprotective effect of polycyclic phenolic compounds through synergistic interaction with antioxidants
FR2766092B1 (en) 1997-07-16 1999-10-08 Centre Nat Rech Scient IMPLANTABLE DEVICE COATED WITH A POLYMER CAPABLE OF RELEASING BIOLOGICALLY ACTIVE SUBSTANCES
US6900186B1 (en) 1999-06-21 2005-05-31 Murdock Children's Research Institute Method for the prophylaxis and/or treatment of medical disorders
WO2004072284A1 (en) * 2003-02-11 2004-08-26 Antisense Therapeutics Ltd Modulation of insulin like growth factor i receptor expression

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100099D0 (en) * 1991-01-11 1991-01-11 Kabi Pharmacia Ab USE OF GROWTH FACTOR
US5298422A (en) * 1991-11-06 1994-03-29 Baylor College Of Medicine Myogenic vector systems
EP0750516A4 (en) * 1993-03-26 1998-07-01 Univ Jefferson Method of inhibiting the proliferation and causing the differentiation of cells with igf-1 receptor antisense oligonucleotides

Also Published As

Publication number Publication date
WO1996010401A1 (en) 1996-04-11

Similar Documents

Publication Publication Date Title
AU6772996A (en) 2-acylaminopropanamides as growth hormone secretagogues
AU4257289A (en) Method for controlling the growth of cartilage
EP0815201A4 (en) Methods for microbial regulation
AU2695795A (en) Piperazine compounds promote release of growth hormone
AU5549896A (en) 3-substituted piperidines promote release of growth hormone
AU5855796A (en) Methods for inhibiting bone loss
AU3265495A (en) Plant growth promoter
AU3028995A (en) Binding agent for growth factor
AU6724496A (en) 2-acylaminopropanamines as growth hormone secretagogues
AU7081094A (en) Cell growth factor receptors
AU6858596A (en) Compounds for stimulating nerve growth
AU6043096A (en) Methods for minimizing bone loss
AU7427091A (en) Composition for the regulation of hair growth
AU7891098A (en) Method for elevating the concentration of free insulin-like growth factor
AU3207195A (en) Growth stimulating factors
AU3760595A (en) Methods for regulation of insulin-like growth factor i receptor
AU3835697A (en) Method for inhibiting the growth of mammalian cells
AU9014898A (en) Method for tightening artist's canvas
AU5743396A (en) Methods for inhibiting bone loss
AU1942995A (en) New use of growth hormone
AU2611695A (en) Sailboatsystem for controlled gibing
AU3282695A (en) Method for adjusting consistency
AU4630397A (en) Agents for the regulation of oestrogen synthesis
AU4453396A (en) Growth factor analogs
AU5743696A (en) Methods for inhibiting bone loss